---
id: tissue-nematodes-strongyloides-hookworm_100
category: organisms
tags: [strongyloides, hookworm, nematodes, hyperinfection-syndrome, ivermectin]
deck: Infectious Diseases
created: 2025-11-10
modified: 2025-11-10
---

## Tissue Nematodes: Strongyloides & Hookworm

**Q:** What are the clinical features, complications, and treatment of Strongyloides stercoralis (including hyperinfection syndrome) and hookworm infection?

**A:**

## OVERVIEW

| **Feature** | **Strongyloides stercoralis** | **Hookworm** (*Ancylostoma*, *Necator*) |
|-------------|-------------------------------|------------------------------------------|
| **Transmission** | **Skin penetration** (filariform larvae in soil) + **Autoinfection** | **Skin penetration** (filariform larvae in soil) |
| **Key Clinical Feature** | **Hyperinfection syndrome** (immunosuppressed) | **Iron-deficiency anemia** |
| **Unique Feature** | **Autoinfection** (can persist decades without re-exposure) | **NO autoinfection** (cannot persist without re-exposure) |
| **Diagnosis** | Stool O&P, serology, agar plate | Stool O&P (eggs) |
| **Treatment** | **Ivermectin** (2 doses, 2 weeks apart) | **Albendazole** OR **Mebendazole** (single/short course) |

**Key Point:** **Strongyloides = autoinfection** → can persist for life, **hyperinfection in immunosuppressed**

---

## 1. STRONGYLOIDES STERCORALIS (STRONGYLOIDIASIS)

**Organism:** *Strongyloides stercoralis* (intestinal nematode/roundworm)

**Transmission:**
- **Skin penetration** of filariform larvae (walking barefoot on contaminated soil)
- **Autoinfection** (unique to Strongyloides):
  - **Rhabditiform larvae → filariform larvae** in intestine → penetrate colonic mucosa or perianal skin
  - **Allows chronic infection for decades** without re-exposure

**Epidemiology:**
- **Endemic:** Tropical/subtropical regions (Southeast Asia, sub-Saharan Africa, Latin America)
- **US:** Appalachia, rural Southeast, immigrants/veterans
- **~30-100 million infected** worldwide

---

### **Life Cycle:**

1. **Filariform larvae** penetrate skin → Bloodstream → Lungs
2. **Ascend trachea** → Swallowed → Small intestine
3. **Adult female worms** (parthenogenetic) in duodenum/jejunum → Lay eggs
4. **Eggs hatch** → **Rhabditiform larvae** in intestine → Excreted in stool
5. **Autoinfection:** Rhabditiform → Filariform in intestine → Penetrate colonic mucosa → Restart cycle

**Key Point:** **Autoinfection = unique feature** (chronic infection for decades without re-exposure)

---

### **Clinical Features:**

---

#### **A. Acute Infection (Initial Penetration):**

**Dermatologic:**
- **"Ground itch"** at penetration site (pruritic maculopapular rash - feet/legs)

**Pulmonary (Larval Migration - "Löffler syndrome"):**
- **Cough, dyspnea, wheezing**
- **Eosinophilic pneumonitis**
- **Transient infiltrates** on CXR

**Key Point:** Similar to hookworm acute infection

---

#### **B. Chronic Infection (Most Common):**

**Asymptomatic (50-75%):**
- **Eosinophilia** only finding

**Gastrointestinal:**
- **Epigastric pain** (mimics peptic ulcer disease)
- **Diarrhea, constipation**
- **Nausea, anorexia, weight loss**

**Dermatologic:**
- **Larva currens** ("racing larva"):
  - **Pathognomonic** for Strongyloides
  - **Serpiginous, pruritic, urticarial rash** (rapidly migrating - inches per hour)
  - **Buttocks, thighs, trunk** (autoinfection larvae migrating through skin)

**Laboratory:**
- **Eosinophilia** (50-80%) - may be absent in hyperinfection

**Key Point:** **Larva currens = pathognomonic** for Strongyloides (rapidly migrating urticarial rash)

---

#### **C. Hyperinfection Syndrome (Immunosuppressed):**

**Definition:** Accelerated autoinfection with larvae in GI/pulmonary systems (confined to migration route)

**Disseminated Strongyloidiasis:** Larvae in extraintestinal sites (CNS, liver, kidney - beyond migration route)

**Risk Factors:**
- **Corticosteroids** (most important - even low/moderate doses)
- **HTLV-1 coinfection**
- **Hematologic malignancies**
- **Solid organ/hematopoietic stem cell transplant**
- **HIV** (less common risk than above)

**Clinical Features:**

**Gastrointestinal:**
- **Severe abdominal pain, distension**
- **Ileus, obstruction**
- **GI hemorrhage**

**Pulmonary:**
- **Dyspnea, cough, hemoptysis**
- **Acute respiratory distress syndrome (ARDS)**
- **Diffuse bilateral infiltrates** (CXR)

**Gram-Negative Bacteremia/Meningitis:**
- **Enteric bacteria** carried by migrating larvae (*E. coli*, *Klebsiella*, *Enterococcus*, *Pseudomonas*)
- **Polymicrobial sepsis**
- **Recurrent Gram-negative meningitis** (pathognomonic clue)

**Mortality:** **50-90%** (despite treatment)

**Key Point:** **Hyperinfection in corticosteroid-treated patients** = high mortality (50-90%)

---

### **Diagnosis:**

| **Test** | **Specimen** | **Sensitivity** | **Notes** |
|----------|--------------|-----------------|-----------|
| **Stool O&P (microscopy)** | Stool | **30-50% (single sample)** | Look for **rhabditiform larvae** (NOT eggs)<br>↑ Sensitivity with 3 samples (60-70%) |
| **Agar plate culture** | Stool | **~90%** | **Most sensitive stool test** (larvae leave tracks in agar) |
| **Serology (IgG ELISA)** | Serum | **80-95%** | **Preferred screening test**<br>Remains positive after treatment (cannot assess cure) |
| **Sputum/BAL** | Respiratory | Variable | In hyperinfection (larvae in sputum) |
| **PCR** | Stool | **~90%** | High sensitivity |

**Key Point:** **Serology = preferred screening test** (agar plate = most sensitive stool test)

---

**Screening Recommendations:**

**Screen before immunosuppression if:**
- **Travel/residence in endemic area** (even decades prior)
- **Unexplained eosinophilia**
- **Planned corticosteroid therapy** (transplant, rheumatologic disease, COPD)

**WHO 2024 Guideline:**
- **Empiric ivermectin treatment** before high-dose corticosteroids (if endemic exposure + cannot wait for results)

---

### **Treatment:**

#### **Uncomplicated Strongyloidiasis:**

**First-Line:**

| **Agent** | **Dosing** | **Repeat** |
|-----------|------------|------------|
| **Ivermectin** (preferred) | **200 μg/kg PO x 1 dose** | **Repeat in 2 weeks** |

**Alternative:**

| **Agent** | **Dosing** |
|-----------|------------|
| **Albendazole** | **400 mg PO BID x 7 days** (less effective than ivermectin) |

**Key Point:** **Ivermectin = treatment of choice** (2 doses, 2 weeks apart)

---

#### **Hyperinfection/Disseminated Strongyloidiasis:**

**Treatment:**

| **Agent** | **Dosing** | **Duration** |
|-----------|------------|--------------|
| **Ivermectin** | **200 μg/kg PO/NG daily** | **Until 2 weeks after clearance** (minimum 14 days) |
| **PLUS Albendazole** | **400 mg PO/NG BID** | Same duration |

**Alternative Routes (If Cannot Tolerate Oral):**
- **Subcutaneous ivermectin** (veterinary formulation - FDA IND exemption)
- **Rectal ivermectin** (case reports)

**Additional Management:**
- **Broad-spectrum antibiotics** (Gram-negative coverage - piperacillin-tazobactam OR meropenem)
- **Reduce immunosuppression** (if possible)
- **Monitor stool for larvae** (daily initially, then weekly)

**Key Point:** **Prolonged ivermectin** (until 2 weeks after larvae clearance) + **antibiotics** for hyperinfection

---

### **Prevention:**

- **Screen before immunosuppression** (serology or empiric treatment)
- **Wear shoes** in endemic areas

---

## 2. HOOKWORM (ANCYLOSTOMIASIS/NECATORIASIS)

**Organisms:**
- ***Ancylostoma duodenale*** (Old World hookworm)
- ***Necator americanus*** (New World hookworm)

**Transmission:**
- **Skin penetration** of filariform larvae (walking barefoot on contaminated soil)
- **NO autoinfection** (unlike Strongyloides)

**Epidemiology:**
- **~500 million infected** worldwide
- **Endemic:** Tropical/subtropical regions (sub-Saharan Africa, Southeast Asia, Latin America)
- **Leading cause of iron-deficiency anemia** in developing countries

---

### **Life Cycle:**

1. **Filariform larvae** penetrate skin → Bloodstream → Lungs
2. **Ascend trachea** → Swallowed → Small intestine
3. **Adult worms** attach to duodenal/jejunal mucosa → **Suck blood** (0.03-0.3 mL/worm/day)
4. **Lay eggs** → Excreted in stool → Hatch in soil → Rhabditiform → Filariform larvae

**Key Point:** **NO autoinfection** (requires re-exposure to soil larvae)

---

### **Clinical Features:**

---

#### **A. Acute Infection (Initial Penetration):**

**Dermatologic:**
- **"Ground itch"** at penetration site (pruritic maculopapular rash - feet/legs)

**Pulmonary (Larval Migration - "Löffler syndrome"):**
- **Cough, dyspnea, wheezing**
- **Eosinophilic pneumonitis**

**Key Point:** Similar to Strongyloides acute infection

---

#### **B. Chronic Infection:**

**Gastrointestinal:**
- **Epigastric pain**
- **Diarrhea**
- **Occult GI bleeding** (blood loss from worm attachment sites)

**Anemia (Most Important Complication):**
- **Iron-deficiency anemia** (chronic blood loss)
- **Severity depends on:**
  - Worm burden (heavy infection = severe anemia)
  - Dietary iron intake (low intake → worse anemia)
- **Pallor, fatigue, dyspnea on exertion**
- **Cognitive impairment** (children)
- **Growth retardation** (children)

**Laboratory:**
- **Eosinophilia** (mild-moderate)
- **Hypochromic microcytic anemia** (↓ ferritin, ↓ iron, ↑ TIBC)

**Key Point:** **Hookworm = #1 cause of iron-deficiency anemia** in developing countries

---

### **Diagnosis:**

| **Test** | **Specimen** | **Sensitivity** | **Notes** |
|----------|--------------|-----------------|-----------|
| **Stool O&P (microscopy)** | Stool | **>90%** | Look for **eggs** (oval, thin-walled, 4-8 cell stage) |

**Key Point:** **Stool O&P = see eggs** (NOT larvae - unlike Strongyloides)

---

### **Treatment:**

**First-Line:**

| **Agent** | **Dosing** | **Duration** |
|-----------|------------|--------------|
| **Albendazole** (preferred) | **400 mg PO x 1 dose** | **Single dose** |
| **OR Mebendazole** | **100 mg PO BID** OR **500 mg PO x 1 dose** | **3 days** OR **Single dose** |

**Alternative:**

| **Agent** | **Dosing** |
|-----------|------------|
| **Pyrantel pamoate** | **11 mg/kg PO x 1 dose** (max 1 g) |
| **Ivermectin** | **150-200 μg/kg PO x 1 dose** |

**Adjunctive:**
- **Iron supplementation** (ferrous sulfate 325 mg PO daily) if anemia present

**Key Point:** **Albendazole = single dose** (cure rate ~80%)

---

### **Prevention:**

- **Mass drug administration** (MDA) in endemic areas (albendazole or mebendazole)
- **Wear shoes**
- **Improved sanitation**

---

## COMPARISON TABLE

| **Feature** | **Strongyloides** | **Hookworm** |
|-------------|-------------------|--------------|
| **Autoinfection** | **YES** (can persist for life) | **NO** (requires re-exposure) |
| **Stool finding** | **Rhabditiform larvae** | **Eggs** |
| **Key complication** | **Hyperinfection syndrome** (immunosuppressed) | **Iron-deficiency anemia** |
| **Pathognomonic sign** | **Larva currens** (rapidly migrating urticarial rash) | None |
| **Treatment** | **Ivermectin** 200 μg/kg x 2 doses (2 weeks apart) | **Albendazole** 400 mg x 1 dose |
| **Hyperinfection risk** | **Corticosteroids** (major risk) | None |
| **Screening needed** | **YES** (before immunosuppression) | No |

---

**Mnemonic: "Strongyloides = Steroid Risk (Hyperinfection)"**
- **S**trongyloides
- **S**teroid → **H**yperinfection syndrome
- **A**utoinfection (persists for life)

**Mnemonic: "Larva Currens = Racing Larva (Strongyloides)"**
- **L**arva currens
- **R**acing larva (inches per hour)
- **P**athognomonic for Strongyloides

**Mnemonic: "Hookworm = Hook the Blood (Anemia)"**
- **H**ookworm
- **H**ook to mucosa → suck blood
- **A**nemia (iron-deficiency)

**Mnemonic: "Ivermectin for Strongyloides, Albendazole for Hookworm"**
- **I**vermectin = **S**trongyloides (2 doses)
- **A**lbendazole = **H**ookworm (1 dose)

**Clinical Pearls:**
- **Strongyloides = autoinfection** (can persist for decades without re-exposure)
- **Screen before immunosuppression** (serology or empiric ivermectin if endemic exposure)
- **Larva currens = pathognomonic** (rapidly migrating urticarial rash - buttocks/thighs)
- **Hyperinfection syndrome:** Corticosteroids = major risk (50-90% mortality)
- **Recurrent Gram-negative meningitis** = clue to Strongyloides hyperinfection
- **Ivermectin = treatment of choice** for Strongyloides (200 μg/kg x 2 doses, 2 weeks apart)
- **Hyperinfection treatment:** Ivermectin daily + albendazole until 2 weeks after clearance
- **WHO 2024:** Consider empiric ivermectin before high-dose corticosteroids (if endemic exposure)
- **Hookworm = #1 cause of iron-deficiency anemia** in developing countries
- **Hookworm: NO autoinfection** (requires re-exposure)
- **Stool O&P:** Strongyloides = larvae, Hookworm = eggs
- **Albendazole = single dose** for hookworm (cure rate ~80%)
- **Iron supplementation** essential if anemia present (hookworm)

**Media:** None

**Sources:** [WHO 2024 - Strongyloidiasis public health control guideline], [CDC 2024 - Strongyloides clinical care], [NEJM 2024 - Strongyloidiasis], [Clinical Infectious Diseases 2024 - Ivermectin in hyperinfection], [CDC 2024 - Soil-transmitted helminths clinical care], [Lancet 2024 - Emodepside vs albendazole for hookworm], [Clinical Infectious Diseases 2024 - Albendazole dose-finding for hookworm]
